Loading candles…
Hikal Ltd. operates in the pharmaceuticals, crop protection, specialty chemicals, and life sciences industries, providing active pharmaceutical ingredients (APIs), intermediates, contract development and manufacturing organization (CDMO) services, and research services. The company serves innovator and generic companies globally with integrated research and manufacturing capabilities. Its manufacturing facilities for crop protection products are located in Taloja and Mahad in Maharashtra, while pharmaceutical manufacturing occurs in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's research and development center is based in Pune. These manufacturing facilities have undergone inspection and received approval from leading multinational companies in the crop protection and pharmaceutical sectors. The company has presence in North America, Europe, Japan, and India. No information on founders, key management, subsidiaries, or listings is provided.
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 27 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and dividend | 11 Feb 2026 |
| Unaudited Results - Q2 & FY25 | HIKAL : 13-Nov-2025 : The Company has informed the Exchange that a Board meeting to be held on November 06, 2025 has been re-scheduled. Further, the Company… | 13 Nov 2025 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated financial results for the Quarter and Half Year ended September 30, 2025 | 6 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the unaudited standalone and consolidated financial results for the quarter ended Jun 30, 2025 | 7 Aug 2025 |
| Results - Q4 & FY25 | To consider and approve the financial results for the quarter and the year ended March 31, 2025 and to recommend final dividend, if any | 14 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.